This product line was formulated to satisfy all therapeutic needs of veterinarians.  We pride on the quality, safety and effectiveness standards of our products, as well as on their practical and user-friendly formats. 

Oral paste

Effectrim® is indicated to treat infections of the respiratory, urinary and digestive tracts, among others. 

Acute bacterial respiratory diseases: pneumonia, bronchitis, laryngitis, pleurisy. 

Urogenital diseases: nephritis, pyelonephritis, metritis, cystitis, vaginitis. 

Digestive diseases: enteritis, diarrhea, peritonitis, intestinal infarction, colitis-x, neonatal foal diarrhea. 

Other uses of Effectrim® included the treatment of actinobacillosis, septic arthritis, equine adenitis, omphalitis, and osteomyelitis, among others. 

It may be used concomitantly with pyrimethamine for the treatment of equine protozoal myeloencephalitis caused by sarcocystis neurona. 

Content: 33 g prefilled syringe. 

Ingredients:

  • Sulfadiazine sodium 39.07 g.
  • Trimethoprim 7.81 g.
  • Excipients q. s. 100.00 g.

Flavored oral gel

Rhodocín® is a broad spectrum macrolide antibiotic used for the treatment of bacterial infections, particularly those caused by Rhodococcus equi in foals. 

Its ingredient, azithromycin, may be used alone or concomitantly with rifampicin. 

Rhodocín® is indicated to treat respiratory, dermatologic, urogenital, gastrointestinal, and osteoarticular infections caused by bacteria and coccidia susceptible to azithromycin. 

Open or drained wound and abscess infections caused by Streptococcus spp. or Staphylococcus spp. may be treated with Rhodocín®.

Rhodocín® proved to be effective against gram-negative bacteria found in gastrointestinal infections caused by Escherichia coli, Haemophilus influenzae, Bordetella spp., Mycoplasma pneumoniae, and Toxoplasma spp. 

Content: 36 g prefilled syringe. 

Ingredients:

  • Azithromycin 8.33 g.
  • Excipients q. s. 100.00 g.

Oral gel

Rifamex® is a broad spectrum antibiotic mainly effective against gram-positive bacteria, some gram-negative aerobic bacteria and some facultative anaerobes. 

Since most infections are caused by more than one bacterial species, and because of the ability of these microorganisms to rapidly develop resistance, Rifamex® is generally used concomitantly with other antimicrobial agents. 

The effectiveness of Rifamex® has been demonstrated in the treatment of infections caused by Staphylococcus spp. and in the eradication of pathogens located in places inaccessible to other antimicrobial drugs, such as the inside of phagocytic cells. It also showed in-vitro activity against Corynebacterium pseudotuberculosis, Lawsonia intracellularis, Rhodococcus equi, species of Staphylococcus, Streptococcus equi, S. equisimilis and S. zooepidemicus. 

Rifamex® is used concomitantly with azithromycin for the treatment of pneumonia caused by Rhodococcus (Corynebacterium) equi and equine proliferative enteropathy (Lawsonia intracellularis) in foals. 

The results of in-vitro studies and a vast number of registered cases evidence the synergistic effect of the concomitant use of azithromycin and rifampicin against R. equi, favoring the indication of both drugs over the use of azithromycin alone. 

Content: 36 g prefilled syringe. 

Ingredients:

  • Rifampicin 16.66 g.
  • Excipients q. s. 100.00 g.

Flavored Oral Paste

EFFECTRIM® is a broad-spectrum antimicrobial combination of Sulfonamides and Diaminopyrimidines, indicated to treat bacterial and protozoal infections.

Bacteria (Gram +) that are generally susceptible to such a combination include Streptococcus, Staphylococcus, Clostridium Perfringens, some Fusobacterium and Bacterioides spp, Nocardia spp,

Some bacteria (Gram -) are also susceptible including the Enterobacteriaceae Family, strains of E. Coli, Shigella, Salmonella, klebsiella, Pasteurella and Proteus spp.

Some protozoa, such as Pneumocystis Carinii, Toxoplasma, and coccidia, are also inhibited by the combination.

EFFECTRIM® is indicated to treat Respiratory, Urinary and Digestive Tract Infections, etc. Acute respiratory conditions of bacterial origin (pneumonia, bronchitis, laryngitis, pleurisy). Urogenital conditions (nephritis, pyelonephritis, metritis, cystitis, vaginitis). Digestive disorders (enteritis, diarrhea, peritonitis, intestinal infarction, Colitis X, neonatal diarrhea of ​​foals). Actinobacillosis, septic arthritis, equine adenitis, omphalitis, osteomyelitis, etc. To treat Equine Protozoal Myeloencephalitis caused by Sarcocystis Neurona in combination with Pyrimethamine.

250 g net content 

Ingredients:

  • Sulfadiazine Sodium 42.86 g
  • Trimethoprim 8.50 g
  • Excipients q.s. 100.00 g

Flavored oral gel

RHODOCÍN® is a broad spectrum macrolide antibiotic indicated for bacterial infections treatment, particularly those caused by Rhodococcus equi in foals. Its ingredient, azithromycin, may be used alone or concomitantly with rifampicin.

RHODOCÍN® is indicated to treat respiratory, dermatologic, urogenital, gastrointestinal, and osteoarticular infections caused by bacteria and coccidia susceptible to azithromycin.

Open or drained wound and abscess infections caused by Streptococcus spp. or Staphylococcus spp. may be treated with RHODOCÍN®. 

RHODOCÍN® proved to be effective against gram-negative bacteria found in gastrointestinal infections caused by Escherichia coli, Haemophilus influenzae, Bordetella spp., Mycoplasma pneumoniae, and Toxoplasma spp.

280 g net content 

Ingredients:

  • Azithromycin 20,00 g
  • Excipients q. s. 100,00 g

Flavored oral gel

RIFAMEX® is a broad spectrum antibiotic mainly effective against gram-positive bacteria, some gram-negative aerobic bacteria and some facultative anaerobes.

Since most infections are caused by more than one bacterial species, and because of the ability of these microorganisms to rapidly develop resistance, RIFAMEX® is generally used concomitantly with other antimicrobial agents.

The effectiveness of RIFAMEX® has been demonstrated in the treatment of infections caused by Staphylococcus spp. and in the eradication of pathogens located in places inaccessible to other antimicrobial drugs, such as the inside of phagocytic cells. It also showed in-vitro activity against Corynebacterium pseudotuberculosis, Lawsonia intracellularis, Rhodococcus equi, species of Staphylococcus, Streptococcus equi, S. equisimilis and S. zooepidemicus.

RIFAMEX® is used concomitantly with azithromycin for the treatment of pneumonia caused by Rhodococcus (Corynebacterium) equi and equine proliferative enteropathy (Lawsonia intracellularis) in foals.

The results of in-vitro studies and a vast number of registered cases evidence the synergistic effect of the concomitant use of azithromycin and rifampicin against R. equi, favoring the indication of both drugs over the use of azithromycin alone.

280 g net content 

Ingredients:

  • Rifampicin 20,00 g
  • Excipients q. s. 100,00 g

Lyophilized powder, ready for reconstitute

Equiceft-D® is indicated for the treatment of specific and nonspecific infections caused by germs sensitive to Ceftiofur and also in cases where it is necessary to reduce inflammation and edema.

For the treatment of respiratory tract infections, pneumonia, bone and soft tissues infections, osteomyelitis, septic arthritis, neonatal septicemia, wound infections, Skin infections. Urinary tract infections, placentitis and prostatitis. 

Ingredients:

  • Vial 1
    Ceftiofur sodium 5 g.
  • Vial 2
    Dexamethasone 21-phosphate 0.4 g.
    Water for injection q. s. 100 ml
  • Content:
  • Vial 1
    5 g of Ceftiofur sodium lyophilized powder, ready for reconstitution.
  • Vial 2
    400 mg of Dexamethasone 21-phosphate plus excipients in 100 total ml of solvent.